These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11907107)
1. Preferential infection of immature dendritic cells and B cells by mouse mammary tumor virus. Vacheron S; Luther SA; Acha-Orbea H J Immunol; 2002 Apr; 168(7):3470-6. PubMed ID: 11907107 [TBL] [Abstract][Full Text] [Related]
2. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells. Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703 [TBL] [Abstract][Full Text] [Related]
3. Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen. Baribaud F; Maillard I; Vacheron S; Brocker T; Diggelmann H; Acha-Orbea H J Virol; 1999 Oct; 73(10):8403-10. PubMed ID: 10482591 [TBL] [Abstract][Full Text] [Related]
4. Extrafollicular plasmablast B cells play a key role in carrying retroviral infection to peripheral organs. Finke D; Baribaud F; Diggelmann H; Acha-Orbea H J Immunol; 2001 May; 166(10):6266-75. PubMed ID: 11342650 [TBL] [Abstract][Full Text] [Related]
5. A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection. Vacheron S; Renno T; Acha-Orbea H J Virol; 1997 Oct; 71(10):7289-94. PubMed ID: 9311804 [TBL] [Abstract][Full Text] [Related]
6. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination. Champagne E; Scarpellino L; Lane P; Acha-Orbea H Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566 [TBL] [Abstract][Full Text] [Related]
7. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus. Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306 [TBL] [Abstract][Full Text] [Related]
8. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476 [TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. Held W; Waanders GA; Acha-Orbea H; MacDonald HR J Exp Med; 1994 Dec; 180(6):2347-51. PubMed ID: 7525852 [TBL] [Abstract][Full Text] [Related]
10. Initial stages of mammary tumor virus infection are superantigen independent. Pobezinskaya Y; Chervonsky AV; Golovkina TV J Immunol; 2004 May; 172(9):5582-7. PubMed ID: 15100301 [TBL] [Abstract][Full Text] [Related]
11. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance. Modlin CS; Todd GT; Cohen TD; Fairchild RL Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330 [TBL] [Abstract][Full Text] [Related]
12. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region. Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576 [TBL] [Abstract][Full Text] [Related]
13. CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus. Ando Y; Wajjwalku W; Kishihara K; Arai T; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y Immunobiology; 1996 Aug; 195(3):376-84. PubMed ID: 8877410 [TBL] [Abstract][Full Text] [Related]
14. Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infection. Cabrera G; Burzyn D; Mundiñano J; Courreges MC; Camicia G; Lorenzo D; Costa H; Ross SR; Nepomnaschy I; Piazzon I J Virol; 2008 Aug; 82(15):7422-31. PubMed ID: 18495774 [TBL] [Abstract][Full Text] [Related]
15. Neonatal impaired response to viral superantigen encoded by MMTV(SW) and Mtv-7. Le Bon A; Desaymard C; Papiernik M Int Immunol; 1995 Dec; 7(12):1897-903. PubMed ID: 8746559 [TBL] [Abstract][Full Text] [Related]
16. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells. Penninger JM; Wallace VA; Timms E; Mak TW Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521 [TBL] [Abstract][Full Text] [Related]
17. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells. Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381 [TBL] [Abstract][Full Text] [Related]
18. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus. Held W; Waanders GA; MacDonald HR; Acha-Orbea H Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149 [TBL] [Abstract][Full Text] [Related]
19. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus. Hodes RJ; Novick MB; Palmer LD; Knepper JE J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408 [TBL] [Abstract][Full Text] [Related]
20. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen. Wrona TJ; Lozano M; Binhazim AA; Dudley JP J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]